- Staat
- MN
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 23.11.2022
- Impfdatum
- 23.11.2022
- Beginn
- 23.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Immediate post-injection reaction
Pallor
Syncope
Symptomtext
Approx 1015 am, immediately following 4th vaccine injection (mening) pt. became pale, swayed to the side and fainted. Nurse lowered her to the lfoor slowly, put legs up, by the time she was on the floor, she was awake. She had not eaten breakfast prior to appointment and stated later she has fainted before with vaccination (x1). This was not shared with nurse. Felt completely fine after juice and a snack (15 minutes).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- information regarding previous fainting unknown
- Staat
- TN
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 08.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cold sweat
Dizziness
Hypopnoea
Loss of consciousness
Mydriasis
Pallor
Seizure like phenomena
Vomiting
Symptomtext
After administering Tdap and Meningococcal vaccines patient stated she felt dizzy. Patient had a loss of consciouness and began having seizure like activity. After about 15 seconds patient regained consciouness. Patient appeared pale and skin was cool and clammy. Pupils dilated without PERRLA. Breathing shallow and unlabored. Patient A&O x3. Patient had vomiting epidsode x1. Patient laid on back with legs elevated above head. Cool compress placed on forehead. Patient observed for 1 hour and became more alert. Blood pressure, heart rate, and O2 saturation maintained within normal limits throughout event. After 1 hour no distress noted and vital signs within normal range. Patient left ambulatory. Mother called pediatrician to make appointment for follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- No Known Allergies
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 23.08.2022
- Impfdatum
- 23.08.2022
- Beginn
- 23.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal discomfort
Asthenia
Dizziness
Fatigue
Headache
Hyperhidrosis
Pallor
Syncope
Symptomtext
Shortly after injection (~5 minutes), Patient felt dizzy and lightheaded and without much warning experienced a syncopal episode (diaphoretic, pale, and fainting) . She was assessed by on-site RN and CNP and EMS was called per pharmacy protocol/policy. Vital signs remained good throughout, including blood pressure and heart rate. No itching or swelling noted, no shortness of breath or rash. Neurologically intact. She was feeling much better within 10-15 minutes and was cleared to go home. Patient continued with a headache, upset stomach, and weakness/fatigue for the remainder of the day but otherwise is doing okay.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Assessment by CNP including head-to-toe exam, blood pressure including orthostatic blood pressures, all within normal limits. Blood glucose was 79.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Anxiety, mild intermittent asthma
- Andere Medikamente
- Sertraline 100 mg, Junel BCP
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 20.09.2022
- Impfdatum
- 19.09.2022
- Beginn
- 19.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Blood glucose decreased
Blood test abnormal
Chest X-ray abnormal
Chills
Dyspnoea
Hallucination
Hypoaesthesia
Pleurisy
Vomiting
Symptomtext
Per his mother , the patient experienced vomiting, chills, hallucinations, left sided numbness of the face and body and difficulty breathing. The patient was taken by ambulance the the emergency department.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Per the mother , the patient received bloodwork that revealed low blood sugar and a chest x-ray that revealed pleurisy. The patient was discharged at 4:00 am 9/20/2022.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- seasonal allergies
- Andere Medikamente
- unknown
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 02.08.2023
- Impfdatum
- 02.08.2023
- Beginn
- 02.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Symptomtext
The mother of the patient called to let the us know that her daughter's left leg above her knee started hurting once she got home shortly after getting her shots. The patient was not having any chest pain, was not having any shortness of breath and was not having any difficulty breathing at the time of my call. The patient's pediatrician is Dr. I advised the mother of the patient to consult with the pediatrician. I advised the mother to take the patient to the ER if new s&s develop and to also call the pediatrician.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 25.10.2022
- Impfdatum
- 25.10.2022
- Beginn
- 25.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Headache
Injection site pain
Lip swelling
Pharyngeal swelling
Streptococcus test negative
Symptomtext
Went to bed with head ache on 09/12/2022 and on 0913/2022 woke up with lips swollen and throat feeling swollen. Pain at injection site. Mom took patient to ER.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- Strep test done and neg. Dismissed from ER with Tylenol to use PRN and Prednisone to start.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- ADHD
- Andere Medikamente
- Focalin XR 15 mg once daily
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 23.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 23.09.2022
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Symptomtext
Mother called today to say that school nurse noted that childs arm near injection site was swollen and red (golf ball sized). The mother said that the nurse also told her that the child had been scratching the area and the mother stated she wasn't sure if it wasn't a mosquito bite. I advised mother to take the child to the pediatrician to have it checked out.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None known
- Vorgeschichte
- Unknown
- Andere Medikamente
- Mother denies any other medications
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 11,0
- Geschlecht
- U
- Eingang
- 12.09.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Diarrhoea
Headache
Urticaria
Vomiting
Symptomtext
hives in the chest area; vomiting; diarrhea; headache; Initial information received on 26-Aug-2022 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 11 years old and unknown gender patient who experienced hives in the chest area, vomiting, diarrhea and headache after receiving vaccine meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received 0.5 ml dose of suspect meningococcal A-C-Y-W135 (T CONJ) vaccine ,solution for injection (strength not reported) (lot U7299AA; Expiration 04-Aug-2024) via unknown route in unknown administration site for Immunization. On an unknown date the patient developed hives in the chest area (urticaria), vomiting, diarrhea (diarrhoea), headache (unknown latency). It was reported " Nurse called to report that one of their patient, an 11-year-old received MENQUADFI and after three days of immunization experienced hives in the chest area, vomiting, diarrhea and headache. Nurse just wants to know if these are adverse effects of the vaccine and if she needs to report this as clinic protocol." Action taken : not applicable. It was not reported if the patient received a corrective treatment for all the events. At time of reporting, the outcome was Unknown for all the events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 06.09.2022
- Impfdatum
- 30.08.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Cellulitis
Injection site erythema
Injection site pain
Injection site pruritus
Injection site swelling
Symptomtext
Injection site became red, swollen, painful and itchy spreading downward to elbow. Seen in ER 3 days after immunization and diagnosed with cellulitis. Started Rx with Keflex and oral steroid
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- no
- Allergien
- Peanuts, tree nuts, shellfish
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 15.08.2022
- Beginn
- 18.08.2022
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Diarrhoea
Headache
Urticaria
Vomiting
Symptomtext
3 days post vaccination developed hives to chest, vomiting, diarrhea, and headache.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 08.08.2022
- Impfdatum
- 05.08.2022
- Beginn
- 06.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Rash
Rash pruritic
Symptomtext
Patient's mother calls to report that day after receiving her vaccines (8/6/22) she developed an itchy rash in the front, middle part of her chin spreading down her chest. Patient's mother denies any SOB, difficulty breathing, or any signs of anaphylaxis. With consult of provider, instructed patient's mother to provide the patient with oral Benadryl and also can apply a topical Benadryl as well. Patient's mother verbalizes an understanding. Will call the patient in 2-3 days to follow up on symptoms. If no improvement is noted, with instruct patient to be seen in the clinic for further evaluation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Vitamin D and Vitamin C Probiotic combination.
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 04.08.2022
- Impfdatum
- 31.07.2022
- Beginn
- 31.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Flushing
Hyperhidrosis
Nausea
Vomiting
Symptomtext
Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Systemic: Vomiting-Medium
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 02.08.2022
- Impfdatum
- 02.08.2022
- Beginn
- 02.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Fall
Symptomtext
Patient received the vaccines and walked through hallway to grab water. On his way back to the room, he fell in the hallway. Patient was helped up to nearby bench by staff and mother, and eventually helped ambulate back to room and laid down on exam table where he was examined by his provider. Provider gave clearance to leave after that Patient did not lose consciousness, just says he felt a little dizzy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- Zithromax
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 20.04.2023
- Impfdatum
- 06.04.2023
- Beginn
- 06.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Tdap vaccine expired 4/1/2023, given 4/6/2023 0 adverse reaction to patient known
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- No
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 26.01.2023
- Impfdatum
- 22.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
ADOLESCENT COVID BOOSTER GIVEN TO AN 11 YO PATIENT
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- -
- Geschlecht
- U
- Eingang
- 13.10.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Poor quality product administered
Product storage error
Symptomtext
Menquadfi in the refrigerator and unmonitored for 1 week due to a provider removing the data logger and not putting it back in the refrigerator with no reported adverse event; Menquadfi was administered to 1 patient during the time the product was unmonitored in the refrigerator with no reported adverse event; Initial information received on 07-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case US-SA-2022SA417024. This case involves an unknown age and unknown gender patient who was administered meningococcal a-c-y-w135 (t conj) vaccine [menquadfi] which was kept in the refrigerator and unmonitored for 1 week due to a provider removing the data logger and not putting it back in the refrigerator with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect meningococcal a-c-y-w135 (t conj) vaccine (Solution for injection) (lot U7299AA; expiry date: 04-Aug-2024) (strength, route unknown) via intramuscular route in unknown administration site for Prophylactic vaccination (Immunisation). On an unknown date the patient was administered menquadfi which was kept in the refrigerator and unmonitored for 1 week due to a provider removing the data logger and not putting it back in the refrigerator with no reported adverse event (product storage error) (poor quality product administered). Action taken with meningococcal vaccine was not applicable. At time of reporting, the outcome was Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Poor quality product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 16.08.2022
- Impfdatum
- 09.08.2022
- Beginn
- 09.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
early administration of MENQUADFI booster dose with no reported AE; Initial information received on 09-Aug-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 14 years old male patient who had early administration of menquadfi booster dose with no reported adverse event , while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included COVID-19 VACCINE (COVID-19 VACCINE) for Immunisation. On 09-Aug-2022, the patient received a 2nd dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE( lot U7299AA and expiration date: 01-Aug-2024) at an unknown dose (total) via intramuscular route in the deltoid nos for immunization. On 09-Aug-2022 (latency: same day), the patient developed a non-serious event of early administration of menquadfi booster dose with no reported adverse event (inappropriate schedule of product administration) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE. It was reported "the patient first received their dose of MENACTRA at 8 years old due to high risk travel and is now 14 years old and was asking if they were to give the second dose (MENQUADFI) today would that complete the series or will the patient receive a booster shot when the child turns 16 years old. They were informed that the primary dose was valid and that the 2nd dose given was actually considered as too early as per agency." Action taken :not applicable It was not reported if the patient received a corrective treatment for the event . Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01228446:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- COVID-19 VACCINE
- Allergien
- -
- Vorherige Impfungen
- -